| Variable . | . |
|---|---|
| Recipients | |
| Mean age (years) | 48.2 ± 12.7 |
| Females | 42 (31.5%) |
| Mean weight (kg) | 66.1 ± 12.8 |
| Idiopathic dilated cardiomyopathy | 68 (51.1%) |
| Ischaemic cardiomyopathy | 37 (27.8%) |
| Hypertrophic cardiomyopathy | 11 (8.2%) |
| Other aetiologies | 17 (12.9%) |
| PVR (Wood Units) | 2.7 ± 1.3 |
| Postcardiotomy shock | 3 (2.2%) |
| Status 1 | 24 (18.0%) |
| Preoperative IABP | 12 (9.0%) |
| Preoperative VA-ECMO | 6 (4.5%) |
| Preoperative LVAD | 6 (4.5%) |
| Previous cardiac surgery | 36 (27.0%) |
| Donors | |
| Mean age (years) | 43.8 ± 12.7 |
| Donor age ≥60 years | 21 (15.7%) |
| Females | 55 (41.3%) |
| Mean weight (kg) | 75.3 ± 13.2 |
| Mean LOS in ICU (days) | 4.1 ± 4.6 |
| No inotropes | 15 (11.2%) |
| High-dose inotropes | 5 (3.7%) |
| Norepinephrine infusion | 51 (38.3%) |
| Recipient and donor aged ≥60 years | 9 (6.7%) |
| Female donor/male recipient | 23 (17.2%) |
| Weight <30% recipient | 3 (2.2%) |
| Transplantation data | |
| Mean ischaemic time (min) | 187.9 ± 52.6 |
| Mean AXC time (min) | 97.8 ± 25.5 |
| Mean CPB time (min) | 216.2 ± 79.7 |
| Variable . | . |
|---|---|
| Recipients | |
| Mean age (years) | 48.2 ± 12.7 |
| Females | 42 (31.5%) |
| Mean weight (kg) | 66.1 ± 12.8 |
| Idiopathic dilated cardiomyopathy | 68 (51.1%) |
| Ischaemic cardiomyopathy | 37 (27.8%) |
| Hypertrophic cardiomyopathy | 11 (8.2%) |
| Other aetiologies | 17 (12.9%) |
| PVR (Wood Units) | 2.7 ± 1.3 |
| Postcardiotomy shock | 3 (2.2%) |
| Status 1 | 24 (18.0%) |
| Preoperative IABP | 12 (9.0%) |
| Preoperative VA-ECMO | 6 (4.5%) |
| Preoperative LVAD | 6 (4.5%) |
| Previous cardiac surgery | 36 (27.0%) |
| Donors | |
| Mean age (years) | 43.8 ± 12.7 |
| Donor age ≥60 years | 21 (15.7%) |
| Females | 55 (41.3%) |
| Mean weight (kg) | 75.3 ± 13.2 |
| Mean LOS in ICU (days) | 4.1 ± 4.6 |
| No inotropes | 15 (11.2%) |
| High-dose inotropes | 5 (3.7%) |
| Norepinephrine infusion | 51 (38.3%) |
| Recipient and donor aged ≥60 years | 9 (6.7%) |
| Female donor/male recipient | 23 (17.2%) |
| Weight <30% recipient | 3 (2.2%) |
| Transplantation data | |
| Mean ischaemic time (min) | 187.9 ± 52.6 |
| Mean AXC time (min) | 97.8 ± 25.5 |
| Mean CPB time (min) | 216.2 ± 79.7 |
High dose inotropes: intravenous dopamine ≥10 μg/kg/min. PVR: basal pulmonary vascular resistance; IABP: intra-aortic balloon pump; VA-ECMO: veno-arterial extracorporeal membrane oxygenation; LVAD: left ventricular assist device; LOS: length of stay; ICU: intensive care unit; AXC: aortic cross clamping; CPB: cardiopulmonary bypass.
| Variable . | . |
|---|---|
| Recipients | |
| Mean age (years) | 48.2 ± 12.7 |
| Females | 42 (31.5%) |
| Mean weight (kg) | 66.1 ± 12.8 |
| Idiopathic dilated cardiomyopathy | 68 (51.1%) |
| Ischaemic cardiomyopathy | 37 (27.8%) |
| Hypertrophic cardiomyopathy | 11 (8.2%) |
| Other aetiologies | 17 (12.9%) |
| PVR (Wood Units) | 2.7 ± 1.3 |
| Postcardiotomy shock | 3 (2.2%) |
| Status 1 | 24 (18.0%) |
| Preoperative IABP | 12 (9.0%) |
| Preoperative VA-ECMO | 6 (4.5%) |
| Preoperative LVAD | 6 (4.5%) |
| Previous cardiac surgery | 36 (27.0%) |
| Donors | |
| Mean age (years) | 43.8 ± 12.7 |
| Donor age ≥60 years | 21 (15.7%) |
| Females | 55 (41.3%) |
| Mean weight (kg) | 75.3 ± 13.2 |
| Mean LOS in ICU (days) | 4.1 ± 4.6 |
| No inotropes | 15 (11.2%) |
| High-dose inotropes | 5 (3.7%) |
| Norepinephrine infusion | 51 (38.3%) |
| Recipient and donor aged ≥60 years | 9 (6.7%) |
| Female donor/male recipient | 23 (17.2%) |
| Weight <30% recipient | 3 (2.2%) |
| Transplantation data | |
| Mean ischaemic time (min) | 187.9 ± 52.6 |
| Mean AXC time (min) | 97.8 ± 25.5 |
| Mean CPB time (min) | 216.2 ± 79.7 |
| Variable . | . |
|---|---|
| Recipients | |
| Mean age (years) | 48.2 ± 12.7 |
| Females | 42 (31.5%) |
| Mean weight (kg) | 66.1 ± 12.8 |
| Idiopathic dilated cardiomyopathy | 68 (51.1%) |
| Ischaemic cardiomyopathy | 37 (27.8%) |
| Hypertrophic cardiomyopathy | 11 (8.2%) |
| Other aetiologies | 17 (12.9%) |
| PVR (Wood Units) | 2.7 ± 1.3 |
| Postcardiotomy shock | 3 (2.2%) |
| Status 1 | 24 (18.0%) |
| Preoperative IABP | 12 (9.0%) |
| Preoperative VA-ECMO | 6 (4.5%) |
| Preoperative LVAD | 6 (4.5%) |
| Previous cardiac surgery | 36 (27.0%) |
| Donors | |
| Mean age (years) | 43.8 ± 12.7 |
| Donor age ≥60 years | 21 (15.7%) |
| Females | 55 (41.3%) |
| Mean weight (kg) | 75.3 ± 13.2 |
| Mean LOS in ICU (days) | 4.1 ± 4.6 |
| No inotropes | 15 (11.2%) |
| High-dose inotropes | 5 (3.7%) |
| Norepinephrine infusion | 51 (38.3%) |
| Recipient and donor aged ≥60 years | 9 (6.7%) |
| Female donor/male recipient | 23 (17.2%) |
| Weight <30% recipient | 3 (2.2%) |
| Transplantation data | |
| Mean ischaemic time (min) | 187.9 ± 52.6 |
| Mean AXC time (min) | 97.8 ± 25.5 |
| Mean CPB time (min) | 216.2 ± 79.7 |
High dose inotropes: intravenous dopamine ≥10 μg/kg/min. PVR: basal pulmonary vascular resistance; IABP: intra-aortic balloon pump; VA-ECMO: veno-arterial extracorporeal membrane oxygenation; LVAD: left ventricular assist device; LOS: length of stay; ICU: intensive care unit; AXC: aortic cross clamping; CPB: cardiopulmonary bypass.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
